Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Domogala

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cytotherapy|April 20, 2016
Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34(+) cellsAnna Domogala, J Alejandro Madrigal, Aurore Saudemont
Frontiers in Immunology|June 20, 2015
Natural Killer Cell Immunotherapy: From Bench to BedsideAnna Domogala, J Alejandro Madrigal, Aurore Saudemont
Transplantation|March 28, 2014
Unique effects of mycophenolate mofetil on cord blood T cells: implications for GVHD prophylaxisSophie Derniame, Fuiyee Lee, Anna Domogala, et al.
Cytotherapy|April 22, 2017
Natural killer cells differentiated in vitro from cord blood CD34<sup>+</sup> cells are more advantageous for use as an immunotherapy than peripheral blood and cord blood natural killer cellsAnna Domogala, Michael Blundell, Adrian Thrasher, et al.
Scientific Reports|February 27, 2016
Regulatory T cells inhibit CD34+ cell differentiation into NK cells by blocking their proliferationIsabela Pedroza-Pacheco, Divya Shah, Anna Domogala, et al.
Plos One|February 4, 2014
Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cellsMartha Luevano, Anna Domogala, Michael Blundell, et al.
Cytotherapy|June 28, 2014
Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2Sophie Derniame, Juliana Perazzo, Fuiyee Lee, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cytotherapy|April 20, 2016
Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34(+) cellsAnna Domogala, J Alejandro Madrigal, Aurore Saudemont
Frontiers in Immunology|June 20, 2015
Natural Killer Cell Immunotherapy: From Bench to BedsideAnna Domogala, J Alejandro Madrigal, Aurore Saudemont
Transplantation|March 28, 2014
Unique effects of mycophenolate mofetil on cord blood T cells: implications for GVHD prophylaxisSophie Derniame, Fuiyee Lee, Anna Domogala, et al.
Cytotherapy|April 22, 2017
Natural killer cells differentiated in vitro from cord blood CD34<sup>+</sup> cells are more advantageous for use as an immunotherapy than peripheral blood and cord blood natural killer cellsAnna Domogala, Michael Blundell, Adrian Thrasher, et al.
Scientific Reports|February 27, 2016
Regulatory T cells inhibit CD34+ cell differentiation into NK cells by blocking their proliferationIsabela Pedroza-Pacheco, Divya Shah, Anna Domogala, et al.
Plos One|February 4, 2014
Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cellsMartha Luevano, Anna Domogala, Michael Blundell, et al.
Cytotherapy|June 28, 2014
Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2Sophie Derniame, Juliana Perazzo, Fuiyee Lee, et al.
Pageof 1